Product Information
FOCALIN XR 30 MG CAPSULE is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $4.7573 per EA under NDC 00078043305. Its NADAC has been published 657 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the dexmethylphenidate hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078043305
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DEXMETHYLPHENIDATE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021802On Market Since
5/31/2005
Pharmacological Classes
Price Statistics
The NADAC for FOCALIN XR 30 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 26.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.7573 per EA |
|---|---|
| All-time high | $13.0729 (Oct 11, 2023) |
| All-time low | $4.7225 (Sep 18, 2024) |
| 52-week high | $4.7684 |
| 52-week low | $4.7304 |
| Median price | $10.9929 |
| Average price | $9.8134 |
| Largest weekly change | -63.8% (Apr 3, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 62% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FOCALIN XR 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FOCALIN XR 30 MG CAPSULE, manufactured by Novartis Pharmaceuticals Corporation, is $4.7573 per EA (NDC 00078043305), effective Jun 24, 2026.
How has the price of FOCALIN XR 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FOCALIN XR 30 MG CAPSULE has declined 26.2%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FOCALIN XR 30 MG CAPSULE?
Since Nov 28, 2013, the NADAC for FOCALIN XR 30 MG CAPSULE has ranged from a low of $4.7225 (Sep 18, 2024) to a high of $13.0729 (Oct 11, 2023), with a median of $10.9929 per EA.
Are there cheaper alternatives to FOCALIN XR 30 MG CAPSULE?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DEXMETHYLPHENIDATE ER 30 MG CP, is $1.7969 per EA — about 62% below FOCALIN XR 30 MG CAPSULE.
Who manufactures FOCALIN XR 30 MG CAPSULE?
FOCALIN XR 30 MG CAPSULE (NDC 00078043305) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.
Related Drugs
Same classification